Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes

Stock Information for MDB Capital Holdings LLC

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MDB Capital Holdings LLC

New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update
MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time
New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol
Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change
MDB Capital Holdings Provides Third Quarter 2024 Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.